RU2001121195A - ((Aminoiminomethyl) amino) alkanecarboxidamides and their use in therapy - Google Patents
((Aminoiminomethyl) amino) alkanecarboxidamides and their use in therapyInfo
- Publication number
- RU2001121195A RU2001121195A RU2001121195/04A RU2001121195A RU2001121195A RU 2001121195 A RU2001121195 A RU 2001121195A RU 2001121195/04 A RU2001121195/04 A RU 2001121195/04A RU 2001121195 A RU2001121195 A RU 2001121195A RU 2001121195 A RU2001121195 A RU 2001121195A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- substituted
- alkylthio
- alkylamino
- trifluoromethyl
- Prior art date
Links
- -1 (Aminoiminomethyl) amino Chemical group 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 26
- 125000006715 (C1-C5) alkylthio group Chemical group 0.000 claims 24
- 125000003545 alkoxy group Chemical group 0.000 claims 24
- 125000003282 alkyl amino group Chemical group 0.000 claims 24
- 125000003277 amino group Chemical group 0.000 claims 24
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 24
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 24
- 150000001875 compounds Chemical class 0.000 claims 16
- 125000005915 C6-C14 aryl group Chemical group 0.000 claims 14
- 125000004093 cyano group Chemical group *C#N 0.000 claims 10
- 229910052736 halogen Inorganic materials 0.000 claims 9
- 150000002367 halogens Chemical class 0.000 claims 9
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims 8
- 125000005354 acylalkyl group Chemical group 0.000 claims 8
- 125000005842 heteroatoms Chemical group 0.000 claims 8
- 229910052757 nitrogen Inorganic materials 0.000 claims 8
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 229910052717 sulfur Inorganic materials 0.000 claims 8
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 6
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 2
- 206010022490 Insulin resistance syndrome Diseases 0.000 claims 2
- 229940079593 drugs Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims 1
- 230000002218 hypoglycaemic Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000001681 protective Effects 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
Claims (11)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9900194A FR2788275B1 (en) | 1999-01-11 | 1999-01-11 | ((AMINOIMINOMETHYL) AMINO) ALKANE CARBOXAMIDES AND THEIR THERAPEUTIC APPLICATIONS |
FR99/00194 | 1999-01-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001121195A true RU2001121195A (en) | 2003-06-27 |
RU2236401C2 RU2236401C2 (en) | 2004-09-20 |
Family
ID=9540749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001121195/04A RU2236401C2 (en) | 1999-01-11 | 1999-12-30 | [(aminoiminomethyl)amino]alkanecarboxidamides and their application in therapy |
Country Status (27)
Country | Link |
---|---|
US (1) | US6518458B1 (en) |
EP (1) | EP1140803B1 (en) |
JP (1) | JP4567889B2 (en) |
KR (1) | KR100630291B1 (en) |
CN (1) | CN1182109C (en) |
AR (1) | AR022221A1 (en) |
AT (1) | ATE252553T1 (en) |
AU (1) | AU760147B2 (en) |
BR (1) | BR9916858A (en) |
CA (1) | CA2359454C (en) |
CZ (1) | CZ20012482A3 (en) |
DE (1) | DE69912315T2 (en) |
DK (1) | DK1140803T3 (en) |
EE (1) | EE200100363A (en) |
ES (1) | ES2207325T3 (en) |
FR (1) | FR2788275B1 (en) |
HK (1) | HK1041689B (en) |
HU (1) | HUP0200023A3 (en) |
ID (1) | ID29586A (en) |
IL (1) | IL144225A0 (en) |
NO (1) | NO20013420L (en) |
NZ (1) | NZ513467A (en) |
PT (1) | PT1140803E (en) |
RU (1) | RU2236401C2 (en) |
SK (1) | SK285130B6 (en) |
WO (1) | WO2000042001A1 (en) |
ZA (1) | ZA200106606B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8017804B2 (en) * | 2004-05-05 | 2011-09-13 | Silence Therapeutics Ag | Lipids, lipid complexes and use thereof |
ES2548515T3 (en) | 2004-12-27 | 2015-10-19 | Silence Therapeutics Gmbh | Lipid complexes coated with PEG and its use |
TW200808705A (en) * | 2006-06-15 | 2008-02-16 | Sanofi Aventis | Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
KR101670085B1 (en) * | 2006-07-21 | 2016-10-28 | 사일런스 테라퓨틱스 게엠베하 | Means for inhibiting the expression of protein kinase 3 |
EP2269980A4 (en) * | 2008-12-24 | 2011-05-18 | Vertex Closed Joint Stock Company | Creatine amides, a method for the production thereof and an agent exhibiting a neuroprotective action |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1153424A (en) * | 1965-04-15 | 1969-05-29 | Horlicks Ltd | Pharmaceutical Compositions |
US5654451B1 (en) * | 1993-01-14 | 2000-02-22 | Magainin Pharma | Amino acids and peptides having modified c-terminals and modified n-terminals |
JPH0841008A (en) * | 1994-07-29 | 1996-02-13 | Ono Pharmaceut Co Ltd | Nitrogen monoxide synthetase inhibitor |
CA2217550A1 (en) * | 1996-10-22 | 1998-04-22 | F. Hoffmann-La Roche Ag | Cationic lipids for gene therapy |
US6395713B1 (en) * | 1997-07-23 | 2002-05-28 | Ribozyme Pharmaceuticals, Inc. | Compositions for the delivery of negatively charged molecules |
DE19748697A1 (en) * | 1997-11-04 | 1999-05-06 | Basf Ag | Process for the preparation of substituted guanidine derivatives |
-
1999
- 1999-01-11 FR FR9900194A patent/FR2788275B1/en not_active Expired - Fee Related
- 1999-12-30 IL IL14422599A patent/IL144225A0/en unknown
- 1999-12-30 CA CA002359454A patent/CA2359454C/en not_active Expired - Fee Related
- 1999-12-30 CZ CZ20012482A patent/CZ20012482A3/en unknown
- 1999-12-30 DK DK99964687T patent/DK1140803T3/en active
- 1999-12-30 RU RU2001121195/04A patent/RU2236401C2/en not_active IP Right Cessation
- 1999-12-30 HU HU0200023A patent/HUP0200023A3/en unknown
- 1999-12-30 EP EP99964687A patent/EP1140803B1/en not_active Expired - Lifetime
- 1999-12-30 ES ES99964687T patent/ES2207325T3/en not_active Expired - Lifetime
- 1999-12-30 WO PCT/EP1999/010468 patent/WO2000042001A1/en active IP Right Grant
- 1999-12-30 NZ NZ513467A patent/NZ513467A/en unknown
- 1999-12-30 SK SK984-2001A patent/SK285130B6/en not_active IP Right Cessation
- 1999-12-30 KR KR1020017008794A patent/KR100630291B1/en not_active IP Right Cessation
- 1999-12-30 CN CNB998155640A patent/CN1182109C/en not_active Expired - Fee Related
- 1999-12-30 BR BR9916858-8A patent/BR9916858A/en not_active Application Discontinuation
- 1999-12-30 EE EEP200100363A patent/EE200100363A/en unknown
- 1999-12-30 US US09/869,957 patent/US6518458B1/en not_active Expired - Lifetime
- 1999-12-30 DE DE69912315T patent/DE69912315T2/en not_active Expired - Lifetime
- 1999-12-30 AT AT99964687T patent/ATE252553T1/en not_active IP Right Cessation
- 1999-12-30 JP JP2000593569A patent/JP4567889B2/en not_active Expired - Fee Related
- 1999-12-30 ID IDW00200101657A patent/ID29586A/en unknown
- 1999-12-30 PT PT99964687T patent/PT1140803E/en unknown
- 1999-12-30 AU AU30443/00A patent/AU760147B2/en not_active Ceased
-
2000
- 2000-01-07 AR ARP000100063A patent/AR022221A1/en unknown
-
2001
- 2001-07-10 NO NO20013420A patent/NO20013420L/en not_active Application Discontinuation
- 2001-08-10 ZA ZA200106606A patent/ZA200106606B/en unknown
-
2002
- 2002-05-07 HK HK02103446.2A patent/HK1041689B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2000131183A (en) | OXYMINO-ALKANIC ACID DERIVATIVES | |
NO20050569L (en) | Procedure for the treatment of severe heart failure and drug for this | |
RU2007101653A (en) | Derivatives of 1-azabicyclo [3.3.1] NONANOV | |
IN2015DN01132A (en) | ||
RU2002124873A (en) | Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing these derivatives, and intermediates for preparing said derivatives | |
RU99109459A (en) | MONOCYCLIC L-NUCLEOSIDS, THEIR ANALOGUES AND APPLICATIONS | |
RU2003134544A (en) | AMRIDES OF ANTRANILIC ACID, METHODS FOR PRODUCING THEM, THEIR APPLICATION AS ANTIARRHYTHMIC MEDICINES, AND ALSO CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS | |
RU2005108133A (en) | DIPEPTIDNITRIL INHIBITORS KATEPSIN K | |
RU2001118826A (en) | N-substituted 2-cyanopyrrolidines | |
RU2000102359A (en) | PHARMACEUTICAL COMPOSITION HAVING AN IMPROVED ANTI-CANCER ACTION AND / OR REDUCED SIDE EFFECTS CONTAINING ANTI-CANCER AGENT AND HYDROXAMIC DERIVATIVE DERIVATIVE | |
RU2006141276A (en) | Purine Derivative | |
RU2003101319A (en) | PHARMACEUTICAL COMPOSITION HAVING AN IMPROVED ANTITUMOR ACTION AND / OR REDUCED SIDE EFFECTS CONTAINING AN ANTITUMOR AGENT AND A DERIVATIVE HYDROGEN | |
RU2004100302A (en) | AMRIDES OF ANTHRANILIC ACID WITH A HETEROARYL SULPHONILY LATERAL CHAIN, METHOD FOR PRODUCING THEM, THEIR APPLICATION AS A MEDICINAL OR DIAGNOSTIC MEDICINE, AND ALSO CONTAINED | |
RU2002135312A (en) | MEANS FOR STRENGTHENING THE GROWTH HORMONE SECRETION | |
RU99101081A (en) | MODE OF INTRODUCTION OF H +, K + -ATPASE INHIBITORS | |
RU2002101622A (en) | Naphthoquinone derivatives and their use for the treatment and control of tuberculosis | |
RU2001113268A (en) | Combined therapy with ribavirin and interferon α to remove hepatitis C virus detected RNA in patients with chronic hepatitis C | |
RU2003130644A (en) | RARCARBOLINE DERIVATIVES AND THEIR PHARMACEUTICAL USE AGAINST DIPRESSION AND FEAR | |
RU2005133093A (en) | COMPOUNDS FOR TREATMENT OF FLAVIVIRAL INFECTIONS | |
JP2006524227A5 (en) | ||
KR940702491A (en) | Oxazolidone derivatives | |
RU2001121195A (en) | ((Aminoiminomethyl) amino) alkanecarboxidamides and their use in therapy | |
RU98119076A (en) | DERIVATIVES OF 2- (3H) -OXASOLONE AND THEIR APPLICATION AS SOX-2 INHIBITORS | |
RU2004107847A (en) | Isoxazolopyridinones and their use in the treatment of Parkinson's disease | |
RU2006104024A (en) | KAPPA-AGONISTS, ESPECIALLY FOR TREATMENT AND / OR PREVENTION OF AN IRRITATED FATIGUE SYNDROME |